drugset / Trial / NCT00327106

Tranexamic Acid in HIp Fracture Surgery (THIF Study)

NCT00327106

Phase 3 Completed 110 enrolled University Hospital of Saint-Etienne
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy of tranexamic acid in hip fracture surgery on the reduction of allogeneic red blood cell transfusion.

Timeline

Start
2005-04
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 15 mg/kg Intravenous

Indications

No indication recorded.